ADC Therapeutics S.A.
ADCT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $235 | $265 | $195 | $251 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $23 | $26 | $32 | $20 |
| Inventory | $18 | $18 | $17 | $18 |
| Other Curr. Assets | $11 | $10 | $14 | $18 |
| Total Curr. Assets | $287 | $319 | $258 | $307 |
| Property Plant & Equip (Net) | $1 | $1 | $13 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $3 | $3 | $15 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $290 | $322 | $273 | $322 |
| Liabilities | – | – | – | – |
| Payables | $8 | $10 | $16 | $18 |
| Short-Term Debt | $1 | $2 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $53 | $53 | $41 | $61 |
| Total Curr. Liab. | $62 | $65 | $58 | $80 |
| LT Debt | $116 | $116 | $449 | $122 |
| Deferred Rev, NC | $0 | $0 | $0 | $320 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $350 | $340 | $4 | $2 |
| Total NC Liab. | $466 | $456 | $453 | $444 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $9 | $9 |
| Total Liabilities | $528 | $521 | $511 | $525 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $10 | $10 | $8 | $8 |
| Retained Earnings | -$1,630 | -$1,589 | -$1,532 | -$1,493 |
| AOCI | -$1 | -$0 | -$1 | -$1 |
| Other Equity | $1,382 | $1,380 | $1,286 | $1,284 |
| Total Equity | -$238 | -$199 | -$238 | -$203 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $290 | $322 | $273 | $322 |
| Net Debt | -$117 | -$147 | $255 | -$128 |